Deka Biosciences – We can build a Diakine™ for every patient.

We can build a Diakine™ for every patient.

Radically changing immunotherapy by developing personalized treatments for inflammatory disease and cancer.

We can build a Diakine™ for every patient.

Radically changing immunotherapy by developing personalized treatments for cancer and inflammatory disease.

We can build a Diakine™ for every patient.

Radically changing immunotherapy by developing personalized treatments for cancer and inflammatory disease.

We can build a Diakine™ for every patient.

Radically changing immunotherapy by developing personalized treatment for cancer and autoimmune patients.

The Diakine™ Platform

Our platform harnesses the potential of the immune system by empowering it to safely combat inflammatory disease and cancer. It is the first therapy to combine two anti-inflammatory cytokines for inflammatory disease, or to combine an immune stimulating cytokine and an anti-inflammatory cytokine into a single treatment for cancer. Through targeting, these powerful cytokine combinations enrich in the affected tissue with the potential to drive disease control.

The Diakine™ platform is a next-generation cytokine therapy created to treat inflammatory disease and cancer based on each patient’s individual immune response.